首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   6篇
  免费   0篇
教育   4篇
科学研究   2篇
  2012年   2篇
  2000年   4篇
排序方式: 共有6条查询结果,搜索用时 656 毫秒
1
1.
常亮  王爱梅  才岩  林宇涵  沈兆亮 《科技通报》2012,28(4):40-42,48
建立小鼠顺铂耳毒性模型,研究不同剂量的顺铂对小鼠耳蜗中Calpain表达水平的影响。将70只成年BALB/c小鼠随机分成4组,用不同剂量的顺铂进行干预后,通过听脑干反应测试用药前后小鼠听力的变化;应用Western blot以及免疫荧光检测耳蜗中Calpain的表达。不同剂量顺铂组小鼠的体重和听力明显下降,随着给药时间的增加,Calpain1在耳蜗中的表达水平逐渐减弱,而Calpain2在耳蜗中的表达水平逐渐增强。应用顺铂可建立小鼠耳毒性模型;正常小鼠耳蜗中存在Calpain1和Calpain2的表达,并且calpain2与顺铂所致的耳毒性相关。  相似文献   
2.
目的探讨氯化铵(NH4CL)对顺铂(cisplatin,CDDP)抑制A549细胞增殖的影响。方法体外培养人肺癌A549细胞,MTT法检测NH4CL及CDDP对人肺癌A549细胞增殖率的影响;光镜下观察NH4CL及CDDP对A549细胞生长的影响;共聚焦显微镜下观察A549细胞核的形态变化。结果与对照组相比,给予不同浓度的NH4CL及CDDP导致A549细胞增殖率明显下降;光镜下观察A549细胞经非毒性剂量的NH4CL与CDDP联合应用处理后细胞生长抑制明显高于单独给予CDDP组;共聚焦显微镜观察可见非毒性剂量的NH4CL与CDDP联合应用处理A549细胞核碎裂现象明显多于单独CDDP处理组。结论 NH4CL可以促进CDDP对A549A细胞的凋亡诱导作用。  相似文献   
3.
INTRODUCTIONCis diamminedichloroplatinum (Ⅱ ) (Cis platin)isawidelyusedantineoplasticagentthathasnephrotoxicityasamajordose limitingsideeffect.Themostcommonformofcisplatin in ducedrenaltoxicityisnon oliguricacuterenalfailure.Theunderlyingmechanismofthisrena…  相似文献   
4.
The present study was undertaken to clarify the pathogenesis of cisplatin-induced acute renal failure at the early stage. Male Sprague-Dawley rats were given an intravenous administration of 10 mg/kg cisplatin. 0.9% saline was infused into them at a rate of 2 ml/h for 3 h, starting with a 2-ml bolus injection before cisplatin administration. 3 h following cisplatin administration, no evident morphological abnormalities were found by both light and electron microscopy; there were also no significant changes in GFR. Thirty min after cisplatin injection, urine sodium and potassium excretion increased by 56% and 260% those of the control animals, respectively. Apparent renal mitochondrial respiration dysfunction was observed in cisplatintreated rats 3 h later; the state 4 respiration increased by 100% and state 3 respiration, respiratory control ratio and carbonyl cyanide p-trifluoromethoxyphenyl hydrazone-uncoupled respiration decreased by 46%, 74% and 47% of the controls, respectively. The present data suggest that mitochondrial dysfunction may be a very early event in cisplatin-induced acute renal failure in rats.  相似文献   
5.
This study was carried out to elucidate the nephroprotective effects from a mixture of 8 L-amino acids and the possible mechanism of protection by this amino acid mixture. Acute renal failure model was induced by an intravenous administration of 10 mg/kg cisplatin to male Sprague-Dawley rats. A mixture of 8 L-amino acids or 0.9% saline was infused at a rate of 2 ml/h for 3 h, starting with a 2 ml bolus injection before cisplatin administration. Amino acids showed no acute effect on renal morphology. The infusion of a mixture of 8 L-amino acids increased GFR by 85% in control rats. The abnormalities of urine sodium and potassium excretion caused by cisplatin were markedly attenuated by the administration of the amino acid mixture. With the infusion of this amino acid mixture, cisplatin-induced abnormal state 4 respiration returned to control levels and the depressed state 3 respiration, respiratory control ratio and carbonyl cyanide p-trifluoromethoxyphenyl hydrazone-uncoupled respiration were ameliorated remarkably. A mixture of 8 L-amino acids showed marked nephroprotection against cisplatin-induced acute renal failure in rats and might function through augmentation of the cisplatin-injured renal mitochondrial electron transport-oxidative phosphorylation sequence, probably via stabilizing the membrane (including inner mitochondrial membrane) protein tertiary structure. In addition, this amino acid mixture remarkably increased GFR and decreased urine sodium excretion in rats.  相似文献   
6.
INTRODUCTIONAcuterenalfailure(ARF),usuallyreferredtoasacutetubularnecrosis,isacommonsyndromecharacterizedbyanabruptandsustaineddeclineinglomerularfiltrationwithresultantazotemia,causedbyacuteischemicand/ortoxicinjuries.Itisnotimmediatelyreversiblewhenca…  相似文献   
1
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号